BioCentury
ARTICLE | Financial News

Xencor amends IPO

November 11, 2013 8:00 AM UTC

Xencor Inc., Monrovia, Calif. Business: Cancer, Autoimmune, Computational chemistry/biology Date announced: 11/4/13 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwrit...